259 related articles for article (PubMed ID: 19118007)
1. Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome.
Christensen BC; Houseman EA; Godleski JJ; Marsit CJ; Longacker JL; Roelofs CR; Karagas MR; Wrensch MR; Yeh RF; Nelson HH; Wiemels JL; Zheng S; Wiencke JK; Bueno R; Sugarbaker DJ; Kelsey KT
Cancer Res; 2009 Jan; 69(1):227-34. PubMed ID: 19118007
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of lung adenocarcinoma, pleural mesothelioma, and nonmalignant pulmonary tissues using DNA methylation profiles.
Christensen BC; Marsit CJ; Houseman EA; Godleski JJ; Longacker JL; Zheng S; Yeh RF; Wrensch MR; Wiemels JL; Karagas MR; Bueno R; Sugarbaker DJ; Nelson HH; Wiencke JK; Kelsey KT
Cancer Res; 2009 Aug; 69(15):6315-21. PubMed ID: 19638575
[TBL] [Abstract][Full Text] [Related]
3. [Pulmonary concentration of asbestos fibers in steel workers with pleural mesothelioma].
Barbieri PG; Somigliana A; Festa R; Bercich L
G Ital Med Lav Ergon; 2010; 32(2):149-53. PubMed ID: 20684435
[TBL] [Abstract][Full Text] [Related]
4. Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma.
Christensen BC; Godleski JJ; Marsit CJ; Houseman EA; Lopez-Fagundo CY; Longacker JL; Bueno R; Sugarbaker DJ; Nelson HH; Kelsey KT
Carcinogenesis; 2008 Aug; 29(8):1555-9. PubMed ID: 18310086
[TBL] [Abstract][Full Text] [Related]
5. Integrated profiling reveals a global correlation between epigenetic and genetic alterations in mesothelioma.
Christensen BC; Houseman EA; Poage GM; Godleski JJ; Bueno R; Sugarbaker DJ; Wiencke JK; Nelson HH; Marsit CJ; Kelsey KT
Cancer Res; 2010 Jul; 70(14):5686-94. PubMed ID: 20587528
[TBL] [Abstract][Full Text] [Related]
6. An asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutation.
Cheung M; Kadariya Y; Pei J; Talarchek J; Facciolo F; Visca P; Righi L; Cozzi I; Testa JR; Ascoli V
Cancer Genet; 2015 Oct; 208(10):502-7. PubMed ID: 26364129
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma.
Goto Y; Shinjo K; Kondo Y; Shen L; Toyota M; Suzuki H; Gao W; An B; Fujii M; Murakami H; Osada H; Taniguchi T; Usami N; Kondo M; Hasegawa Y; Shimokata K; Matsuo K; Hida T; Fujimoto N; Kishimoto T; Issa JP; Sekido Y
Cancer Res; 2009 Dec; 69(23):9073-82. PubMed ID: 19887624
[TBL] [Abstract][Full Text] [Related]
8. The role of epigenetics in malignant pleural mesothelioma.
Vandermeers F; Neelature Sriramareddy S; Costa C; Hubaux R; Cosse JP; Willems L
Lung Cancer; 2013 Sep; 81(3):311-318. PubMed ID: 23790315
[TBL] [Abstract][Full Text] [Related]
9. Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects.
Guarrera S; Viberti C; Cugliari G; Allione A; Casalone E; Betti M; Ferrante D; Aspesi A; Casadio C; Grosso F; Libener R; Piccolini E; Mirabelli D; Dianzani I; Magnani C; Matullo G
J Thorac Oncol; 2019 Mar; 14(3):527-539. PubMed ID: 30408567
[TBL] [Abstract][Full Text] [Related]
10. Asbestos burden predicts survival in pleural mesothelioma.
Christensen BC; Godleski JJ; Roelofs CR; Longacker JL; Bueno R; Sugarbaker DJ; Marsit CJ; Nelson HH; Kelsey KT
Environ Health Perspect; 2008 Jun; 116(6):723-6. PubMed ID: 18560526
[TBL] [Abstract][Full Text] [Related]
11. The relationship between tumor MSLN methylation and serum mesothelin (SMRP) in mesothelioma.
Nelson HH; Almquist LM; LaRocca JL; Plaza SL; Lambert-Messerlian GM; Sugarbaker DJ; Bueno R; Godleski JJ; Marsit CJ; Christensen BC; Kelsey KT
Epigenetics; 2011 Aug; 6(8):1029-34. PubMed ID: 21775819
[TBL] [Abstract][Full Text] [Related]
12. [Asbestos fibre lung burden and exposure indices in asbestos-cement workers].
Barbieri PG; Somigliana A; Lombardi S; Girelli R; Benvenuti A
Med Lav; 2009; 100(1):21-8. PubMed ID: 19263869
[TBL] [Abstract][Full Text] [Related]
13. Methylation-associated Silencing of microRNA-126 and its Host Gene EGFL7 in Malignant Pleural Mesothelioma.
Andersen M; Trapani D; Ravn J; Sørensen JB; Andersen CB; Grauslund M; Santoni-Rugiu E
Anticancer Res; 2015 Nov; 35(11):6223-9. PubMed ID: 26504055
[TBL] [Abstract][Full Text] [Related]
14. Analysis of asbestos concentration in 20 cases of pseudomesotheliomatous lung cancer.
Dodson RF; Hammar SP
Ultrastruct Pathol; 2015 Feb; 39(1):13-22. PubMed ID: 24830353
[TBL] [Abstract][Full Text] [Related]
15. [Molecular heterogeneity of malignant pleural mesotheliomas].
Tranchant R; Montagne F; Jaurand MC; Jean D
Bull Cancer; 2018 Jan; 105(1):35-45. PubMed ID: 29277245
[TBL] [Abstract][Full Text] [Related]
16. Translocation of inhaled asbestos fibers from the lung to other tissues.
Suzuki Y; Kohyama N
Am J Ind Med; 1991; 19(6):701-4. PubMed ID: 1882849
[TBL] [Abstract][Full Text] [Related]
17. Familial mesothelioma of the pleura--a report of 40 cases.
Bianchi C; Brollo A; Ramani L; Bianchi T; Giarelli L
Ind Health; 2004 Apr; 42(2):235-9. PubMed ID: 15128174
[TBL] [Abstract][Full Text] [Related]
18. Screening for malignant pleural mesothelioma and lung cancer in individuals with a history of asbestos exposure.
Roberts HC; Patsios DA; Paul NS; DePerrot M; Teel W; Bayanati H; Shepherd F; Johnston MR
J Thorac Oncol; 2009 May; 4(5):620-8. PubMed ID: 19357540
[TBL] [Abstract][Full Text] [Related]
19. [Malignant mesothelioma of the pleura among women].
Bianchi C; Bianchi T; Ramani L
Med Lav; 2004; 95(5):376-80. PubMed ID: 15595200
[TBL] [Abstract][Full Text] [Related]
20. Identification of a mesothelioma phenotype.
Ohar JA; Ampleford EJ; Howard SE; Sterling DA
Respir Med; 2007 Mar; 101(3):503-9. PubMed ID: 16919927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
